This dissertation aims to accurately identify the radiation dose during treatment with radioactive iodine for differentiated thyroid cancer. The study initially focused on the application of personalised patient treatment using advanced 124I-positron emission tomography (PET). Based on the results, 124I-PET imaging provides valuable prognostic information that can support personalised therapy using radioactive iodine. In addition, advanced dosage calculations can result in cost-effective screening improvements for rooms in which therapeutic treatment using radioactive iodine takes place
Objective: Evaluate the efficacy of cumulative doses (CDs) of 131I-iodide therapy (RIT) in different...
The most frequent thyroid cancer is Differentiated Thyroid Cancer (DTC) representing more than 95% o...
The most frequent thyroid cancer is Differentiated Thyroid Cancer (DTC) representing more than 95% o...
This dissertation aims to accurately identify the radiation dose during treatment with radioactive i...
Background: Differentiated thyroid cancer has been treated with radioiodine for almost 80 years, alt...
Radioiodine therapy (RIT) is an integral component in the treatment of differentiated thyroid cancer...
Radioactive iodine is utilized commonly for ablation of remnant thyroid tissue after thyroidectomy a...
Although radioactive iodine imaging and therapy are one of the earliest applications of theranostics...
Pembedahan tiroid diikuti oleh rawatan radioaktif iodin-131 untuk memusnahkan mana-mana sel tiroid y...
Nowadays, it is crucial to deal with the dosimetry issues in the light of 2013/59 EURATOM recommenda...
Radioactive iodine (RAI) therapy using 131I can be used to treat patients with thyroid dysfunction s...
Aims When a fixed activity of radioiodine is given for differentiated thyroid cancer (DTC), absorbed...
The treatment of differentiated thyroid cancer has three main modalities: surgery, hormone suppress...
Thyroid cancer is rare. With the increase of sophisticated diagnostic imaging modalities, the number...
PURPOSE: Dosimetry is rarely performed for the treatment of differentiated thyroid cancer patients w...
Objective: Evaluate the efficacy of cumulative doses (CDs) of 131I-iodide therapy (RIT) in different...
The most frequent thyroid cancer is Differentiated Thyroid Cancer (DTC) representing more than 95% o...
The most frequent thyroid cancer is Differentiated Thyroid Cancer (DTC) representing more than 95% o...
This dissertation aims to accurately identify the radiation dose during treatment with radioactive i...
Background: Differentiated thyroid cancer has been treated with radioiodine for almost 80 years, alt...
Radioiodine therapy (RIT) is an integral component in the treatment of differentiated thyroid cancer...
Radioactive iodine is utilized commonly for ablation of remnant thyroid tissue after thyroidectomy a...
Although radioactive iodine imaging and therapy are one of the earliest applications of theranostics...
Pembedahan tiroid diikuti oleh rawatan radioaktif iodin-131 untuk memusnahkan mana-mana sel tiroid y...
Nowadays, it is crucial to deal with the dosimetry issues in the light of 2013/59 EURATOM recommenda...
Radioactive iodine (RAI) therapy using 131I can be used to treat patients with thyroid dysfunction s...
Aims When a fixed activity of radioiodine is given for differentiated thyroid cancer (DTC), absorbed...
The treatment of differentiated thyroid cancer has three main modalities: surgery, hormone suppress...
Thyroid cancer is rare. With the increase of sophisticated diagnostic imaging modalities, the number...
PURPOSE: Dosimetry is rarely performed for the treatment of differentiated thyroid cancer patients w...
Objective: Evaluate the efficacy of cumulative doses (CDs) of 131I-iodide therapy (RIT) in different...
The most frequent thyroid cancer is Differentiated Thyroid Cancer (DTC) representing more than 95% o...
The most frequent thyroid cancer is Differentiated Thyroid Cancer (DTC) representing more than 95% o...